BCL2L11 and cancer: However, excessive Bim activation may lead to neurodegenerative diseases, liver damage and diabetes, while reduced Bim expression is associated with autoimmune diseases, increased risk for cancer development and poor response of malignant cells to chemotherapeutics (Figure 8).